These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 16116033)
21. Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes derived from idiopathic myelofibrosis and non-neoplastic haematopoiesis. Bock O; Neusch M; Büsche G; Mengel M; Kreipe H Eur J Haematol; 2004 Apr; 72(4):239-44. PubMed ID: 15089760 [TBL] [Abstract][Full Text] [Related]
22. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525 [TBL] [Abstract][Full Text] [Related]
23. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone. Pullarkat V; Bedell V; Kim Y; Bhatia R; Nakamura R; Forman S; Sun J; Senitzer D; Slovak ML Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862 [TBL] [Abstract][Full Text] [Related]
24. The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis. Schneeweiss M; Peter B; Bibi S; Eisenwort G; Smiljkovic D; Blatt K; Jawhar M; Berger D; Stefanzl G; Herndlhofer S; Greiner G; Hoermann G; Hadzijusufovic E; Gleixner KV; Bettelheim P; Geissler K; Sperr WR; Reiter A; Arock M; Valent P Haematologica; 2018 May; 103(5):799-809. PubMed ID: 29439183 [TBL] [Abstract][Full Text] [Related]
25. Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2. Noskova V; Bottalico B; Olsson H; Ehinger A; Pilka R; Casslén B; Hansson SR Mol Hum Reprod; 2006 Aug; 12(8):483-9. PubMed ID: 16567367 [TBL] [Abstract][Full Text] [Related]
26. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Sotlar K; Horny HP; Simonitsch I; Krokowski M; Aichberger KJ; Mayerhofer M; Printz D; Fritsch G; Valent P Am J Surg Pathol; 2004 Oct; 28(10):1319-25. PubMed ID: 15371947 [TBL] [Abstract][Full Text] [Related]
27. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion. Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603 [TBL] [Abstract][Full Text] [Related]
28. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture. Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021 [TBL] [Abstract][Full Text] [Related]
29. [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder]. Lorenzo-Sanz G; Sánchez-Herranz A Rev Neurol; 2011 Mar; 52 Suppl 1():S103-8. PubMed ID: 21365590 [TBL] [Abstract][Full Text] [Related]
30. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system. Hansson SR; Hoffman BJ; Mezey E Brain Res Dev Brain Res; 1998 Sep; 110(1):135-58. PubMed ID: 9733951 [TBL] [Abstract][Full Text] [Related]
31. [Using real-time polymerase chain reaction to quantitate bcr-abl mRNA]. Liu JX; Liu JL; Wang GJ Ai Zheng; 2006 Nov; 25(11):1447-9. PubMed ID: 17094919 [TBL] [Abstract][Full Text] [Related]
32. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells]. Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781 [TBL] [Abstract][Full Text] [Related]
33. Expression of the basophil-specific antibodies 2D7 and BB1 in patients with cutaneous Mastocytosis. Idoate MA; Echeveste J; Gil P; Sanz ML; Ferrer M J Investig Allergol Clin Immunol; 2013; 23(6):392-7. PubMed ID: 24459815 [TBL] [Abstract][Full Text] [Related]
34. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia. Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279 [TBL] [Abstract][Full Text] [Related]
35. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia. Lee J; Kim Y; Lim J; Kim M; Han K Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925 [TBL] [Abstract][Full Text] [Related]
36. Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature. Kocabas CN; Yavuz AS; Lipsky PE; Metcalfe DD; Akin C J Allergy Clin Immunol; 2005 Jun; 115(6):1155-61. PubMed ID: 15940128 [TBL] [Abstract][Full Text] [Related]
37. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Sperr WR; Drach J; Hauswirth AW; Ackermann J; Mitterbauer M; Mitterbauer G; Foedinger M; Fonatsch C; Simonitsch-Klupp I; Kalhs P; Valent P Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6787-92. PubMed ID: 16203765 [TBL] [Abstract][Full Text] [Related]
38. Expression of alpha-tryptase and beta-tryptase by human basophils. Jogie-Brahim S; Min HK; Fukuoka Y; Xia HZ; Schwartz LB J Allergy Clin Immunol; 2004 Jun; 113(6):1086-92. PubMed ID: 15208589 [TBL] [Abstract][Full Text] [Related]
39. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease. Stevens EC; Rosenthal NS Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063 [TBL] [Abstract][Full Text] [Related]
40. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia. Zhao Z; Tang X; You Y; Li W; Liu F; Zou P Leuk Res; 2006 Aug; 30(8):993-1003. PubMed ID: 16448696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]